Consistent with the findings in CRC cell lines, CEA−/lo xhCRC cells demonstrated higher tumor-initiating capacity (Figure 3C–3D, Table 2 and Supplementary Table S2) and developed larger tumors than CEA+ cells (Figure 3C–3E and Supplementary Table S2). The gene discussed is CEACAM5; the disease is colorectal carcinoma.